|
台北市內湖區健康中心防疫資訊 http://nhu-tpc.doh.gov.tw/pub/LIT_10.asp Agarwal, R., Elbishbishi, E. A., Chaturvedi, U. C., Nagar, R., and Mustafa, A. S. (1999). Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever. Int J Exp Pathol 80, 143-149. Amberg, S. M., Nestorowicz, A., McCourt, D. W., and Rice, C. M. (1994). NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J Virol 68, 3794-3802. Anderson, R., Wang, S., Osiowy, C., and Issekutz, A. C. (1997). Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 71, 4226-4232. Avirutnan, P., Malasit, P., Seliger, B., Bhakdi, S., and Husmann, M. (1998). Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161, 6338-6346. Bosio, C. F., Thomas, R. E., Grimstad, P. R., and Rai, K. S. (1992). Variation in the efficiency of vertical transmission of dengue-1 virus by strains of Aedes albopictus (Diptera: Culicidae). J Med Entomol 29, 985-989. Castro, M. G., Nogueira, R. M., Schatzmayr, H. G., Miagostovich, M. P., and Lourenco-de-Oliveira, R. (2004). Dengue virus detection by using reverse transcription-polymerase chain reaction in saliva and progeny of experimentally infected Aedes albopictus from Brazil. Mem Inst Oswaldo Cruz 99, 809-814. Chakravarti, A., and Kumaria, R. (2006). Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res 123, 25-30. Charnsilpa, W., Takhampunya, R., Endy, T. P., Mammen, M. P., Jr., Libraty, D. H., and Ubol, S. (2005). Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro. J Med Virol 77, 89-95. Chen, W. J., Chen, S. L., Chien, L. J., Chen, C. C., King, C. C., Harn, M. R., Hwang, K. P., and Fang, J. H. (1996). Silent transmission of the dengue virus in southern Taiwan. Am J Trop Med Hyg 55, 12-16. Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., and Marks, R. M. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3, 866-871. Choochote, W., Tippawangkosol, P., Jitpakdi, A., Sukontason, K. L., Pitasawat, B., Sukontason, K., and Jariyapan, N. (2001). Polygamy: the possibly significant behavior of Aedes aegypti and Aedes albopictus in relation to the efficient transmission of dengue virus. Southeast Asian J Trop Med Public Health 32, 745-748. Chua, J. J., Bhuvanakantham, R., Chow, V. T., and Ng, M. L. (2005). Recombinant non-structural 1 (NS1) protein of dengue-2 virus interacts with human STAT3beta protein. Virus Res 112, 85-94. Couvelard, A., Marianneau, P., Bedel, C., Drouet, M. T., Vachon, F., Henin, D., and Deubel, V. (1999). Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol 30, 1106-1110. Czajkowski, R., Drewa, T., Wozniak, A., and Krzyzynska-Malinowska, E. (2002). Cell cycle in sporadic melanoma. Int J Dermatol 41, 550-556. De Paula, S. O., and Fonseca, B. A. (2004). Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 8, 390-398. De Paula, S. O., Nunes, C., Matos, R., de Oliveira, Z. M., Lima, D. M., and da Fonseca, B. A. (2001). Comparison of techniques for extracting viral RNA from isolation-negative serum for dengue diagnosis by the polymerase chain reaction. J Virol Methods 98, 119-125. el-Deiry, W. S., Harper, J. W., O''Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., and et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54, 1169-1174. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825. el-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescu, V. E., Burrell, M., Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., and et al. (1995). Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55, 2910-2919. Falconar, A. K. (1997). The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142, 897-916. Ferreira, M. L., Cavalcanti, C. G., Coelho, C. A., and Mesquita, S. D. (2005). [Neurological manifestations of dengue: study of 41 cases.]. Arq Neuropsiquiatr 63, 488-493. Forwood, J. K., Brooks, A., Briggs, L. J., Xiao, C. Y., Jans, D. A., and Vasudevan, S. G. (1999). The 37-amino-acid interdomain of dengue virus NS5 protein contains a functional NLS and inhibitory CK2 site. Biochem Biophys Res Commun 257, 731-737. Garcia-Cordero, J., Ramirez, H. R., Vazquez-Ochoa, M., Gutierrez-Castaneda, B., Santos-Argumedo, L., Villegas-Sepulveda, N., and Cedillo-Barron, L. (2005). Production and characterization of a monoclonal antibody specific for NS3 protease and the ATPase region of Dengue-2 virus. Hybridoma (Larchmt) 24, 160-164. Gartel, A. L., and Tyner, A. L. (1999). Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246, 280-289. Gil, L., Martinez, G., Tapanes, R., Castro, O., Gonzalez, D., Bernardo, L., Vazquez, S., Kouri, G., and Guzman, M. G. (2004). Oxidative stress in adult dengue patients. Am J Trop Med Hyg 71, 652-657. Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., and Mathieu, C. (2001). An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25, 386-401. Green, S., Vaughn, D. W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Lew, R., Innis, B. L., Kurane, I., Rothman, A. L., and Ennis, F. A. (1999). Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179, 755-762. Gubler, D. J. (1998). Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11, 480-496. Gunther, I., Glatthaar, B., Doller, G., and Garten, W. (1993). A H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unusual cleavage site. Virus Res 27, 147-160. Guzman, M. G., and Kouri, G. (2002). Dengue: an update. Lancet Infect Dis 2, 33-42. Hahn, Y. S., Galler, R., Hunkapiller, T., Dalrymple, J. M., Strauss, J. H., and Strauss, E. G. (1988). Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology 162, 167-180. Hall, W. C., Crowell, T. P., Watts, D. M., Barros, V. L., Kruger, H., Pinheiro, F., and Peters, C. J. (1991). Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg 45, 408-417. Halstead, S. B. (1989). Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 11 Suppl 4, S830-839. Halstead, S. B., and O''Rourke, E. J. (1977). Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265, 739-741. Hathirat, P., Isarangkura, P., Srichaikul, T., Suvatte, V., and Mitrakul, C. (1993). Abnormal hemostasis in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 24 Suppl 1, 80-85. Ho, L. J., Wang, J. J., Shaio, M. F., Kao, C. L., Chang, D. M., Han, S. W., and Lai, J. H. (2001). Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 166, 1499-1506. Hober, D., Nguyen, T. L., Shen, L., Ha, D. Q., Huong, V. T., Benyoucef, S., Nguyen, T. H., Bui, T. M., Loan, H. K., Le, B. L., et al. (1998). Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: relationship between virus detection and pre-existing specific antibodies. J Med Virol 54, 210-218. Hober, D., Poli, L., Roblin, B., Gestas, P., Chungue, E., Granic, G., Imbert, P., Pecarere, J. L., Vergez-Pascal, R., Wattre, P., and et al. (1993). Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48, 324-331. Huang, Y. H., Chang, B. I., Lei, H. Y., Liu, H. S., Liu, C. C., Wu, H. L., and Yeh, T. M. (1997). Antibodies against dengue virus E protein peptide bind to human plasminogen and inhibit plasmin activity. Clin Exp Immunol 110, 35-40. Huang, Y. H., Lei, H. Y., Liu, H. S., Lin, Y. S., Liu, C. C., and Yeh, T. M. (2000). Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63, 71-75. Hung, S. L., Lee, P. L., Chen, H. W., Chen, L. K., Kao, C. L., and King, C. C. (1999). Analysis of the steps involved in Dengue virus entry into host cells. Virology 257, 156-167. Hunter, T., and Pines, J. (1994). Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582. Jacobs, M. G., Robinson, P. J., Bletchly, C., Mackenzie, J. M., and Young, P. R. (2000). Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. Faseb J 14, 1603-1610. Jan, J. T., Chen, B. H., Ma, S. H., Liu, C. I., Tsai, H. P., Wu, H. C., Jiang, S. Y., Yang, K. D., and Shaio, M. F. (2000). Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. J Virol 74, 8680-8691. Johnson, D. G., and Walker, C. L. (1999). Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39, 295-312. Jones, M., Davidson, A., Hibbert, L., Gruenwald, P., Schlaak, J., Ball, S., Foster, G. R., and Jacobs, M. (2005). Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 79, 5414-5420. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51, 6304-6311. Kawano, H., Rostapshov, V., Rosen, L., and Lai, C. J. (1993). Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol 67, 6567-6575. Krishnamurti, C., and Alving, B. (1989). Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes. Rev Infect Dis 11 Suppl 4, S843-846. Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R., Strauss, E. G., et al. (2002). Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725. Kurane, I., Rothman, A. L., Livingston, P. G., Green, S., Gagnon, S. J., Janus, J., Innis, B. L., Nimmannitya, S., Nisalak, A., and Ennis, F. A. (1994). Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl 9, 59-64. Lane, D. P. (1992). Cancer. p53, guardian of the genome. Nature 358, 15-16. Lei, H. Y., Yeh, T. M., Liu, H. S., Lin, Y. S., Chen, S. H., and Liu, C. C. (2001). Immunopathogenesis of dengue virus infection. J Biomed Sci 8, 377-388. Lin, C. F., Lei, H. Y., Shiau, A. L., Liu, H. S., Yeh, T. M., Chen, S. H., Liu, C. C., Chiu, S. C., and Lin, Y. S. (2002). Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol 169, 657-664. Lin, S. R., Hsieh, S. C., Yueh, Y. Y., Lin, T. H., Chao, D. Y., Chen, W. J., King, C. C., and Wang, W. K. (2004). Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution. J Virol 78, 12717-12721. Lin, Y. L., Liu, C. C., Chuang, J. I., Lei, H. Y., Yeh, T. M., Lin, Y. S., Huang, Y. H., and Liu, H. S. (2000). Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology 276, 114-126. Littaua, R., Kurane, I., and Ennis, F. A. (1990). Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144, 3183-3186. Marianneau, P., Cardona, A., Edelman, L., Deubel, V., and Despres, P. (1997). Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol 71, 3244-3249. Marianneau, P., Flamand, M., Deubel, V., and Despres, P. (1998). Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited. Clin Diagn Virol 10, 113-119. Matsuda, T., Almasan, A., Tomita, M., Tamaki, K., Saito, M., Tadano, M., Yagita, H., Ohta, T., and Mori, N. (2005). Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol 86, 1055-1065. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. (1994). Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54, 3391-3395. Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2004). Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313-319. Munoz-Jordan, J. L., Sanchez-Burgos, G. G., Laurent-Rolle, M., and Garcia-Sastre, A. (2003). Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100, 14333-14338. Murgue, B., Cassar, O., Guigon, M., and Chungue, E. (1997). Dengue virus inhibits human hematopoietic progenitor growth in vitro. J Infect Dis 175, 1497-1501. Nguyen, T. H., Lei, H. Y., Nguyen, T. L., Lin, Y. S., Huang, K. J., Le, B. L., Lin, C. F., Yeh, T. M., Do, Q. H., Vu, T. Q., et al. (2004). Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189, 221-232. Noor, R., Mittal, S., and Iqbal, J. (2002). Superoxide dismutase--applications and relevance to human diseases. Med Sci Monit 8, RA210-215. Pereira, S. P., Langley, P. G., and Williams, R. (1996). The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 16, 403-414. Perez, A. B., Garcia, G., Sierra, B., Alvarez, M., Vazquez, S., Cabrera, M. V., Rodriguez, R., Rosario, D., Martinez, E., Denny, T., and Guzman, M. G. (2004). IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73, 230-234. Quaresma, J. A., Barros, V. L., Pagliari, C., Fernandes, E. R., Guedes, F., Takakura, C. F., Andrade, H. F., Jr., Vasconcelos, P. F., and Duarte, M. I. (2006). Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virology 345, 22-30. Randolph, V. B., Winkler, G., and Stollar, V. (1990). Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology 174, 450-458. Roehrig, J. T., Volpe, K. E., Squires, J., Hunt, A. R., Davis, B. S., and Chang, G. J. (2004). Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein. J Virol 78, 2648-2652. Rosen, L. (1987). Sexual transmission of dengue viruses by Aedes albopictus. Am J Trop Med Hyg 37, 398-402. Rothman, A. L. (2004). Dengue: defining protective versus pathologic immunity. J Clin Invest 113, 946-951. Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H. G., Krajewski, S., Reed, J. C., Hoffman, B., and Liebermann, D. (1994). Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9, 1791-1798. Sen, C. K., and Packer, L. (1996). Antioxidant and redox regulation of gene transcription. Faseb J 10, 709-720. Sherr, C. J. (1993). Mammalian G1 cyclins. Cell 73, 1059-1065. Sherr, C. J., and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512. Smith, G. W., and Wright, P. J. (1985). Synthesis of proteins and glycoproteins in dengue type 2 virus-infected vero and Aedes albopictus cells. J Gen Virol 66 (Pt 3), 559-571. Stocks, C. E., and Lobigs, M. (1998). Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J Virol 72, 2141-2149. Sundaresan, M., Yu, Z. X., Ferrans, V. J., Sulciner, D. J., Gutkind, J. S., Irani, K., Goldschmidt-Clermont, P. J., and Finkel, T. (1996). Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 318 (Pt 2), 379-382. Tan, B. H., Fu, J., Sugrue, R. J., Yap, E. H., Chan, Y. C., and Tan, Y. H. (1996). Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology 216, 317-325. Thongtan, T., Panyim, S., and Smith, D. R. (2004). Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol 72, 436-444. Valero, N., Espina, L. M., Anez, G., Torres, E., and Mosquera, J. A. (2002). Short report: increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg 66, 762-764. Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., and Nisalak, A. (2000). Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181, 2-9. Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., and Harris, C. C. (1996). The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 10, 1219-1232. Yusof, R., Clum, S., Wetzel, M., Murthy, H. M., and Padmanabhan, R. (2000). Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem 275, 9963-9969. Zhang, Y., Zhang, W., Ogata, S., Clements, D., Strauss, J. H., Baker, T. S., Kuhn, R. J., and Rossmann, M. G. (2004). Conformational changes of the flavivirus E glycoprotein. Structure 12, 1607-1618.
|